Monitor for any subsequent amendments to this 13G for stake changes, or a potential conversion to a 13D if Bellevue's intent changes. The 10.6% position is large enough to be a meaningful holder, but the passive certification and institutional profile (Swiss asset manager) make an activist campaign unlikely.
Price Chart
Executive Summary
Bellevue Group AG, a Swiss asset manager, filed a Schedule 13G disclosing a 10.6% passive stake in Yarrow Bioscience (VYNE), representing 1,000,000 shares. This is a new filing by Bellevue, not an amendment, and the stake is based on 9,437,693 shares outstanding as of September 14, 2026, after an equity offering. The passive nature and institutional identity suggest a routine investment, not an activist precursor.
Key Financial Metrics
Key Facts
- Bellevue Group AG filed a new Schedule 13G disclosing beneficial ownership of 1,000,000 shares of Yarrow Bioscience common stock.
- The stake represents 10.6% of shares outstanding, based on 9,437,693 shares outstanding as of September 14, 2026.
- Bellevue Asset Management AG, a wholly-owned subsidiary, is also named as a reporting person.
- The filing is passive under Rule 13d-1(b), with no intent to influence or change control of the issuer.
- The stake was acquired as of September 10, 2026, shortly after the issuer's equity offering closed on September 14, 2026.
Financial Impact
10.6% passive stake valued at an undisclosed amount; no direct financial impact from the filing itself.
Risk Factors
- A 10.6% stake concentrated in a single institutional holder could lead to selling pressure if Bellevue reduces its position.
- The stake was acquired shortly after an equity offering, suggesting the shares may have been purchased in the offering at a discount, potentially overhanging the stock.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G Filing (Primary) | 0001104659-26-114282 |
| Document: 0001104659-26-114282-index.html | 0001104659-26-114282 |
| Document: 0001104659-26-114282.txt | 0001104659-26-114282 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 7, 2026 20d ago | SC 13G | — | awaiting T+20 | — | — |
Jul 29, 2026 12w ago | 3 | $28.05 | awaiting T+20 | — | — |
Jul 21, 2026 14w ago | 8-K | $0.8927 | awaiting T+20 | — | — |
Jul 14, 2026 15w ago | 425 / 8-K | $0.7110 | awaiting T+20 | — | — |
Jul 10, 2026 15w ago | 425 / 8-K | $0.6376 | awaiting T+20 | — | — |
Jun 17, 2026 18w ago | EFFECT | $0.6311 $0.7675 | ▲ +21.61% | ▲ +20.30% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers